IDENTIFICATION OF THE SPECIFIC HEMATOPOIETIC STEM CELL POPULATIONS RESPONSIBLE FOR FAILURE TO HYPOMETHYLATING AGENTS IN MYELODYSPLASTIC SYNDROMES

被引:0
|
作者
Ganan-Gomez, I. [1 ]
Alfonso, A. [1 ]
Ogoti, Y. [1 ]
Yang, H. [1 ]
Montalban-Bravo, G. [1 ]
Yu, A. C. [2 ]
Silver, S. [2 ]
Clise-Dwyer, K. [1 ]
Garcia-Manero, G. [1 ]
Colla, S. [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Leukemia, Houston, TX 77030 USA
[2] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Houston, TX 77030 USA
关键词
D O I
10.1016/S0145-2126(17)30165-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
52
引用
收藏
页码:S34 / S36
页数:3
相关论文
共 50 条
  • [41] Hematopoietic Stem Cell Transplantation for Older Patients With Myelodysplastic Syndromes
    Deeg, H. Joachim
    de Lima, Marcos
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2013, 11 (10): : 1227 - 1233
  • [42] Feasibility of hypomethylating agents followed by allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome
    Kim, D-Y
    Lee, J-H
    Park, Y-H
    Lee, J-H
    Kim, S-D
    Choi, Y.
    Lee, S-B
    Lee, K-H
    Ahn, S. Y.
    Lee, Y-S
    Seol, M.
    Kang, Y-A
    Jeon, M.
    Jung, A. R.
    Lee, Y-J
    Lee, K-H
    BONE MARROW TRANSPLANTATION, 2012, 47 (03) : 374 - 379
  • [43] Feasibility of hypomethylating agents followed by allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome
    D-Y Kim
    J-H Lee
    Y-H Park
    J-H Lee
    S-D Kim
    Y Choi
    S-B Lee
    K-H Lee
    S Y Ahn
    Y-S Lee
    M Seol
    Y-A Kang
    M Jeon
    A R Jung
    Y-J Lee
    K-H Lee
    Bone Marrow Transplantation, 2012, 47 : 374 - 379
  • [44] FEASIBILITY OF HYPOMETHYLATING AGENTS FOLLOWED BY ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION IN PATIENTS WITH MYELODYSPLASTIC SYNDROME
    Park, Y. H.
    Lee, J. H.
    Kim, D. Y.
    Lee, J. H.
    Lim, S. N.
    Kim, S. D.
    Choi, Y.
    Lee, S.
    Lee, K. H.
    Kim, J. Y.
    Lee, Y. S.
    Seol, M.
    Kang, Y. A.
    Jeon, M.
    Lee, Y. J.
    Lee, K. H.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 128 - 128
  • [45] Clinical outcome after failure of hypomethylating therapy for myelodysplastic syndromes
    Carella, Angelo M.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2015, 94 (06) : 463 - 463
  • [46] Failure of Hypomethylating Agent-Based Therapy in Myelodysplastic Syndromes
    Kadia, Tapan M.
    Jabbour, Elias
    Kantarjian, Hagop
    SEMINARS IN ONCOLOGY, 2011, 38 (05) : 682 - 692
  • [47] Clinicopathologic Predictors of Hypomethylating Agent Failure in Patients with Myelodysplastic Syndromes
    Chien, Kelly S.
    Urrutia, Samuel
    Li, Ziyi
    Kanagal-Shamanna, Rashmi
    Abdelhakeem, Ahmed
    Abuasab, Tareq
    Almanza, Emmanuel
    Gener-Ricos, Georgina
    Bataller, Alex
    Bazinet, Alexandre
    Montalban-Bravo, Guillermo
    Short, Nicholas J.
    Jabbour, Elias
    Kadia, Tapan M.
    Ravandi, Farhad
    Borthakur, Gautam
    Hammond, Danielle E.
    Swaminathan, Mahesh
    Sasaki, Koji
    Dong, Xiao Qin
    Pierce, Sherry
    Kantarjian, Hagop M.
    Garcia-Manero, Guillermo
    BLOOD, 2023, 142
  • [48] Management of patients with higher-risk myelodysplastic syndromes after failure of hypomethylating agents: What is on the horizon?
    Bewersdorf, Jan Philipp
    Zeidan, Amer M.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2021, 34 (01)
  • [49] Epigenetics in focus: Pathogenesis-of myelodysplastic syndromes and the role of hypomethylating agents
    Santini, Valeria
    Melnick, Ari
    Maciejewski, Jaroslaw P.
    Duprez, Estelle
    Nervi, Clara
    Cocco, Lucio
    Ford, Kevin G.
    Mufti, Ghulam
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2013, 88 (02) : 231 - 245
  • [50] SOMATIC MUTATIONAL MODEL TO PREDICT RESPONSE TO HYPOMETHYLATING AGENTS IN MYELODYSPLASTIC SYNDROMES
    Nazha, A.
    Radivoyevitch, T.
    Thota, S.
    Makishima, H.
    Patel, B.
    Seastone, D.
    Carraway, H.
    Carew, J.
    Przychodzen, B.
    Kalaycio, M.
    Sekeres, M.
    Maciejewski, J.
    LEUKEMIA RESEARCH, 2015, 39 : S9 - S9